Detecting lung cancer mutations in the genes

Israel’s Rosetta Genomics has just had approval from the New Jersey Department of Health, for its OncoGxSelect diagnostic test for lung cancer. The test detects genetic mutations responsible for the tumors and help clinicians make relevant treatment decisions.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *